医学
体外膜肺氧合
医院焦虑抑郁量表
重症监护室
前瞻性队列研究
观察研究
萧条(经济学)
焦虑
外科
内科学
精神科
经济
宏观经济学
作者
Alberto Lucchini,Marta Villa,Marco Giani,Mara Andreossi,Valentino Alessandra,V. Vigo,Stefano Gatti,Daniela Ferlicca,Maddalena Teggia Droghi,Emanuele Rezoagli,Giuseppe Foti,Matteo Pozzi,IRCCS San Gerardo Follow-up group
标识
DOI:10.1016/j.iccn.2024.103631
摘要
Over the last few decades, the use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) support for severe respiratory failure has increased. This study aimed to assess the long-term outcomes of patients treated with VV-ECMO for respiratory failure. We performed a single-centre prospective evaluation of patients on VV-ECMO who were successfully discharged from the intensive care unit of an Italian University Hospital between January 2018 and May 2021. The enrolled patients underwent follow-up evaluations at 6 and 12 months after ICU discharge. The follow-up team performed psychological and functional assessments using the following instruments: Hospital Anxiety and Depression Scale (HADS), Post-traumatic Stress Disorder Symptom Severity Scale (PTSS-10), Euro Quality Five Domains Five Levels (EQ-5L-5D), and 6-minute walk test. We enrolled 33 patients who were evaluated at a follow-up clinic. The median patient age was 51 years (range: 45–58 years). The median duration of VV-ECMO support was 12 (9–19) days and the length of ICU stay was 23 (18–42) days. A HADS score higher than 14 was reported in 8 (24 %) and 7 (21 %) patients at the six- and twelve-month visit, respectively. PTSS-10 total score ≥ 35 points was present in three (9 %) and two (6 %) patients at the six- and twelve-month examination. The median EQ-5L-5D-VAS was respectively 80 (80–90) and 87.5 (70–95). The PTSS-10 score significantly decreased from six to 12 months in COVID-19 survivors (p = 0.024). In this cohort of patients treated with VV-ECMO, cognitive and psychological outcomes were good and comparable to those of patients with Adult Respiratory Distress Syndrome (ARDS) managed without ECMO. The findings of this study confirm the need for long-term follow-up and rehabilitation programs for every ICU survivor after discharge. COVID-19 survivors treated with VV-ECMO had outcomes comparable to those reported in non-COVID patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI